Stock Hot Tips

By Hassan MohammadZaman
Mid East correspondent for crwenewswire.com

Zevotek Inc is expected to increase its brand equity as its Ionic Bulb TV ad has been ranked as 4th most watched household TV ad in the month of June, according to IMS, an independent infomercial industry watcher.

The Ionic Bulb ad was the top ranked household product ad for the week ending June 11th, 2010 as reported by IMS.

Zevotek CEO Rob Babkie stated, “I am pleased to see our June ad blitz is delivering the results we anticipated when we announced our plans last month. Zevotek is working closely with Leisure Time to make sure major retailers take notice. Our TV ads show Americans the Ionic Bulb’s powerful combination of improving a family’s home air quality while instantly saving money on lighting and helping our environment.”

Zevotek Inc. is based in Florida and was founded in 2005. Previously the company was formerly known as Diet Coffee Inc. but later changed its name to Zevotek, Inc. in June 2008. As the name indicates, Zevotek is an US based company that is offering a very innovative range in household products and energy saving fluorescent light bulb under the name of “Ionic Bulb” worldwide.

Their marketing plan for the Ionic Bulbs include the advertisement through television, catalogs, and radio commercials, print advertising, magazines, and various retail and specialty stores.

Their product Ionic Bulb was launched the end of last year and Zevotek claims that their product will not only enlighten the area, but also purify the room like an expansive air purifier.

According to their last financial statement, their total assets keep increasing in number. Retained earning has some negative trend and stood at $4,146 until the last quarter report by the company. Profit margin remained consistent in early reports but it declined in the year end quarterly report. Net income also kept a declining trend throughout the year, except for the middle quarter report, where it improved a little.

Total assets of the company stand around $0.20 million and can be regarded as a highly leveraged company with total liabilities of $1.14 million as per financial statements ending December 31st, 2009

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

By Hassan MohammadZaman
Mid East correspondent for crwenewswire.com

Total E&P Canada Ltd has recently announced that it will acquire the total outstanding common stock of UTS. E&P will pay $3.08 for each share of UTS and the total transaction will amount to $1.5 billion. Both companies are looking forward to establishing a new publicly traded exploration and development company by the name of SilverBirch Energy Corporation.

Other than cash consideration UTS stakeholders will also receive shares of SilverBirch. The company will be established with almost $50 million of working capital and will have 50 percent ownership in both Frontier and Equinox Projects. Once the acquisition is complete the UTS shareholders will own 100 percent of SilverBirch outstanding common stock.

Each shareholder of UTS on completion of transaction will receive $3.08 per UTS share, proportionate shareholding in SilverBrisch with will represent working capital of $0.10 and contingent resources of 1.8 bbls per UTS share.

John Watson, chairman of UTS boar of directors stated that the transaction allows UTS shareholders to realize an immediate cash premium to UTS’ current share price while also participating in the significant growth potential of SilverBirch.

The primary assets with which SilverBirch is going to commence its operations are 50 percent ownership in Equinox and Frontier Projects, 50 percent working interest in 83,714 hectares of oil exploration property, 10 percent interest in 23,040 acres of land in Athabasca Oil sands in Situ oil sands and almost $50 million as working capital.

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

Biomedical News:

Repros Therapeutics Inc. (RPRX)

Last: $0.5798 / Change: +0.0920 (+19.05%)

Recent news: “Repros shares jump on Proellex news” Houston Business Journal Click Here to read more:

Visit:http://www.reprosrx.com

About:

Repros Therapeutics, Inc., a development stage biopharmaceutical company, focuses on the development of oral small molecule drugs for the treatment of male and female reproductive disorders. The company?s primary product candidate includes Androxal that completed Phase IIb proof-of-concept trial in men being treated for low testosterone levels who want to improve or maintain their fertility and/or sperm number and function; and is in the Phase IIa clinical trial for the treatment of hypogonadal men with type 2 diabetes. It also offers phentolamine-based product candidates, including VASOMAX for the treatment of male erectile dysfunction. The company was formerly known as Zonagen, Inc. and changed its name to Repros Therapeutics Inc. in May 2006. Repros Therapeutics, Inc. was founded in 1987 and is based in The Woodlands, Texas.

Power 3 Medical Products Inc. (PWRM.OB)

Last: $0.04

Recent news: “Skymark Research Initiates Independent Research Coverage on Power3 Medical Products, Inc.” Click here to read more:

Visit: www.power3medical.com

About:

Power 3 Medical Products, Inc. is a biotechnology company engaged in the discovery of protein footprints, pathways, and mechanisms of diseases that the Company’s proprietary technology can detect in patients. These discoveries are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer and neurodegenerative disease.

Unigene Laboratories Inc. (UGNE.OB)

Last: $0.79

Recent news: “Unigene Appoints New CEO, Ashleigh Palmer” Click here to read more:

Visit: http://www.unigene.com

About:

Unigene Laboratories, Inc., a biopharmaceutical company, engages in the research, production, and delivery of peptides for medical use primarily in the United States. The company focuses on the development of calcitonin and other peptide products for the treatment of osteoporosis and other indications, including nasal and oral calcitonin, and oral parathyroid hormone (PTH). It offers Fortical, a nasal calcitonin product for the treatment of postmenopausal osteoporosis. Unigene Laboratories has licensing agreements with GlaxoSmithKline to develop an oral formulation of an analog of PTH; Upsher-Smith Laboratories, Inc. to market Fortical; Novartis Pharma AG to manufacture calcitonin; and Tarsa Therapeutics, Inc. to develop Phase III oral calcitonin program. It also has a joint venture agreement with Shijiazhuang Pharmaceutical Group Company, Ltd. for the research, development, and manufacture of recombinant salmon calcitonin and non-oral PTH. The company was founded in 1980 and is based in Boonton, New Jersey.

Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)

StockHotTips.com Hot Stock News & Alerts!

Tuesday December 15, 2009

******************************************************************

ATLANTA, (CRWE NEWSWIRE) — myPhotopipe.com, Inc. (Pink Sheets: MPPC) a web-based online provider of professional digital photo processing, photo finishing, photo sharing, and related services, today announced record sales for November 2009, when compared with the prior-year period, reflecting explosive growth in digital camera sales and the increasing popularity of processing photos online rather than at retail kiosks.

November sales reached a record $152,391, which represented an increase of approximately 3% versus prior-year sales of $148,500. This was the third consecutive month of record sales for the online digital photo processor. The Company also generated a positive EBITDA of $28,798, or 18.9% of sales, for the month of November. “Our focus has been on making our user experience and our products the best in the industry,” stated President Pete Casabonne. “I think we’ve done that. When combined with the incredible shift in demand to online processing, it is easy to see why we think we’re the best pure online digital photo play out there.”

To get the news out, the Company has also increased its own shareholder and market awareness efforts. “We’re trying to tell our story to investors more effectively,” added Casabonne. “When you look at our growth, our customer base, our online tools and digital technologies, you can see why we believe our shares are undervalued. That’s an important mission for us right now – to let prospective shareholders know what this Company is doing and where we’re headed.”

Being at the right place at the right time has also been a driver at myPhotopipe.com. The Company transitioned from film to digital just as digital cameras began to hit the mainstream, then launched a series of sweeping changes earlier this summer that made it dramatically easier to place orders through new web portals and from partner sites. The Company’s Sports and Celebrity customer base includes some of the best known professional sports franchises in the nation, and The Company recently announced a new effort, www.mymodelcomps.com, that allows the Company to enter the multi-billion dollar fashion photography industry. “Models carry ‘comps’ the way executives carry business cards,” continued Casabonne. “We know we can make them look better than anyone out there, and that’s vital to their business. We have the best quality, so this was a natural extension for us.”

About myPhotopipe.com, Inc.

myPhotopipe.com, Inc. is a web-based online provider of digital photo processing, photo finishing, photo sharing, and related services. The Company’s unique blend of 1000 print options, combined with manual print inspections and professional color management, have positioned myPhotopipe.com as one of the fastest-growing providers of digital photography services for professionals and serious amateurs.

The Company is headquartered in Atlanta, Georgia, and its common stock is listed on the OTC Pink Sheets under the symbol “MPPC”. Additional information is available on the Internet at www.myPhotopipe.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, and is subject to the safe harbor created by those sections. Such forward-looking statements are based upon current information and expectations regarding myPhotopipe.com, Inc. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results could materially differ from what is expressed, implied or forecasted in such forward-looking statements.

myPhotopipe.com, Inc. assumes no obligation to update the information contained in this press release. myPhotopipe.com, Inc.’s forward-looking statements in this press release and future results may be materially impacted by any number of factors, any or all of which could have a negative impact on sales, operating results, financial and budgetary constraints. The statements made herein are independent statements of myPhotopipe.com, Inc. The inclusion, if any, of any third parties does not represent an endorsement of any myPhotopipe.com, Inc. products or services by any such third party.

For further information, please contact:

Robert E. Quick, Jr., CEO, at BQuick@myphotopipe.com or 480-614-2221, or visit the Company’s Web site at www.myphotopipe.com.

******************************************************************

***********Advertisement***********

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.Stock Hot Tips publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand dollars from MyPhotopipe.com Inc. (MPPC.PK) for 30 days of advertisement services.